Fortress Biotech Inc (FBIO)
1.61
-0.04
(-2.42%)
USD |
NASDAQ |
Nov 14, 10:50
Fortress Biotech Enterprise Value: -1.023M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -1.023M |
| November 12, 2024 | 0.1178M |
| November 11, 2024 | 1.487M |
| November 08, 2024 | 0.3459M |
| November 07, 2024 | 0.5741M |
| November 06, 2024 | 1.487M |
| November 05, 2024 | 1.601M |
| November 04, 2024 | 0.8022M |
| November 01, 2024 | 4.681M |
| October 31, 2024 | 4.681M |
| October 30, 2024 | 5.593M |
| October 29, 2024 | 7.418M |
| October 28, 2024 | 7.418M |
| October 25, 2024 | 3.540M |
| October 24, 2024 | 0.8022M |
| October 23, 2024 | 1.943M |
| October 22, 2024 | 2.627M |
| October 21, 2024 | 1.943M |
| October 18, 2024 | 3.084M |
| October 17, 2024 | 2.627M |
| October 16, 2024 | 1.258M |
| October 15, 2024 | 0.5741M |
| October 14, 2024 | -0.3385M |
| October 11, 2024 | -1.479M |
| October 10, 2024 | -2.620M |
| Date | Value |
|---|---|
| October 09, 2024 | -2.620M |
| October 08, 2024 | -3.761M |
| October 07, 2024 | -2.392M |
| October 04, 2024 | -1.479M |
| October 03, 2024 | -1.936M |
| October 02, 2024 | -2.848M |
| October 01, 2024 | -6.042M |
| September 30, 2024 | -5.700M |
| September 27, 2024 | -4.673M |
| September 26, 2024 | -5.586M |
| September 25, 2024 | -6.498M |
| September 24, 2024 | -6.954M |
| September 23, 2024 | -6.042M |
| September 20, 2024 | -4.559M |
| September 19, 2024 | 3.312M |
| September 18, 2024 | 5.137M |
| September 17, 2024 | 5.137M |
| September 16, 2024 | 5.593M |
| September 13, 2024 | 6.278M |
| September 12, 2024 | 3.084M |
| September 11, 2024 | 1.487M |
| September 10, 2024 | 1.715M |
| September 09, 2024 | 1.943M |
| September 06, 2024 | 1.715M |
| September 05, 2024 | 3.540M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.71M
Minimum
Nov 10 2023
444.49M
Maximum
Apr 12 2021
102.94M
Average
30.77M
Median
Mar 03 2023
Enterprise Value Benchmarks
| Journey Medical Corp | 102.58M |
| Checkpoint Therapeutics Inc | 157.56M |
| Avenue Therapeutics Inc | -3.065M |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.95M |
| Revenue (Quarterly) | 14.90M |
| Total Expenses (Quarterly) | 40.04M |
| EPS Diluted (Quarterly) | -10.95 |
| Gross Profit Margin (Quarterly) | 56.09% |
| Profit Margin (Quarterly) | -73.50% |
| Earnings Yield | -835.2% |
| Normalized Earnings Yield | -717.01 |